https://www.selleckchem.com/pr....oducts/Sodium-butyra
Administration of DSePA through intraperitoneal (IP) or oral route to mice in a dose range of 2 to 2.5mg/kg body weight has shown survival advantage against whole body irradiation and a significant protection to lung tissue against thoracic irradiation. Pharmacokinetic profiling of DSePA suggests its maximum absorption in the lung. Research work on DSePA reported in fifteen years or so indicates that it is a promising multifunctional organoselenium compound exhibiting many important activities of biological relevance apart from